KevinMD June 26, 2024
Arthur Lazarus, MD, MBA

In early 2022, during the coronavirus pandemic, I considered practicing psychiatry via telehealth. I looked into two telemental-health companies in particular—Cerebral and Done Global, Inc. (hereafter “Done”)—and turned them both down. I did not believe their ethics measured up. In the case of Done, I asked to be withdrawn from consideration as medical director because I believed the company lacked adequate infrastructure and was exclusively focused on treating patients with ADHD.

Sure enough, on June 13, 2024, executives from Done were arrested and charged with fraud. Federal authorities alleged that the founder and clinical president (a psychiatrist) orchestrated a scheme to profit from Adderall prescriptions. DEA administrator Anne Milgram wrote, “The defendants allegedly preyed on Americans and put profits over...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Mental Health, Patient / Consumer, Provider, Technology
The Doctor Will See You… On Amazon: Tech Giant Expands Plans to Merge Medicine with Marketplace
Experts publish framework for global adoption of digital health in medical education
Indiana University Advances Healthcare with Virtual Visits App
There’s a new game in town for D2C health business models
Telehealth Companies Boost Ad Spending While Taking on More Complex Medicine

Share This Article